Sign up for a FREE account to continue your search. |
Bethany Louise Mallino
Examiner (ID: 8674)
Most Active Art Unit | 2925 |
Art Unit(s) | 2925 |
Total Applications | 125 |
Issued Applications | 114 |
Pending Applications | 11 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6750413
[patent_doc_number] => 20030044933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => '96895, a human sodium-hydrogen exchanger family member and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/217096
[patent_app_country] => US
[patent_app_date] => 2002-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 41169
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044933.pdf
[firstpage_image] =>[orig_patent_app_number] => 10217096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/217096 | 96895, a human sodium-hydrogen exchanger family member and uses therefor | Aug 11, 2002 | Abandoned |
Array
(
[id] => 6735153
[patent_doc_number] => 20030012788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Method for influencing kinase pathways with IL-22'
[patent_app_type] => new
[patent_app_number] => 10/206274
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4668
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206274 | Method for influencing kinase pathways with IL-22 | Jul 25, 2002 | Abandoned |
10/070334 | Novel g protein-coupled receptor protein and dna thereof | Jul 11, 2002 | Abandoned |
Array
(
[id] => 579196
[patent_doc_number] => 07449176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Treatment of inflammatory bowel disease with IFN-γ inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/193782
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 19654
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193782 | Treatment of inflammatory bowel disease with IFN-γ inhibitors | Jul 11, 2002 | Issued |
Array
(
[id] => 390061
[patent_doc_number] => 07300656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Treatment of inflammatory bowel disease with IFN-gamma inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/194835
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 19597
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194835 | Treatment of inflammatory bowel disease with IFN-gamma inhibitors | Jul 11, 2002 | Issued |
Array
(
[id] => 6735520
[patent_doc_number] => 20030013155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => '14400 receptor, a novel G-protein coupled receptor'
[patent_app_type] => new
[patent_app_number] => 10/190469
[patent_app_country] => US
[patent_app_date] => 2002-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21789
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190469 | 14400 receptor, a novel G-protein coupled receptor | Jul 4, 2002 | Abandoned |
Array
(
[id] => 6869897
[patent_doc_number] => 20030082586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Antibodies having diagnostic, preventive, therapeutic, and other uses'
[patent_app_type] => new
[patent_app_number] => 10/189123
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 109
[patent_figures_cnt] => 109
[patent_no_of_words] => 59925
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189123 | Antibodies having diagnostic, preventive, therapeutic, and other uses | Jul 1, 2002 | Abandoned |
Array
(
[id] => 6048656
[patent_doc_number] => 20020169151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Inhibition of vascular smooth muscle cell proliferation'
[patent_app_type] => new
[patent_app_number] => 10/185321
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4053
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185321 | Inhibition of vascular smooth muscle cell proliferation | Jun 27, 2002 | Abandoned |
Array
(
[id] => 6846969
[patent_doc_number] => 20030166136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Human C-type lectin'
[patent_app_type] => new
[patent_app_number] => 10/179528
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19967
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10179528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/179528 | Human C-type lectin | Jun 23, 2002 | Abandoned |
Array
(
[id] => 1065793
[patent_doc_number] => 06846919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-25
[patent_title] => 'Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof'
[patent_app_type] => utility
[patent_app_number] => 10/176255
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 23953
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176255 | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof | Jun 18, 2002 | Issued |
Array
(
[id] => 310915
[patent_doc_number] => 07527938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-05
[patent_title] => 'Methods for diagnosis and treatment of chronic immune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/174521
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14888
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/527/07527938.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174521 | Methods for diagnosis and treatment of chronic immune diseases | Jun 16, 2002 | Issued |
Array
(
[id] => 5271538
[patent_doc_number] => 20090075314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'SINGLE-CELL BIOSENSOR FOR THE MEASUREMENT OF GPCR LIGANDS IN A TEST SAMPLE'
[patent_app_type] => utility
[patent_app_number] => 10/161916
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19715
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161916
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161916 | Single-cell biosensor for the measurement of GPCR ligands in a test sample | Jun 3, 2002 | Issued |
Array
(
[id] => 6846936
[patent_doc_number] => 20030166103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Gustducin gamma subunit materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/161941
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8310
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161941 | Gustducin γ subunit materials and methods | Jun 2, 2002 | Issued |
Array
(
[id] => 6692619
[patent_doc_number] => 20030040051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Wnt receptor compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/152548
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8337
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10152548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/152548 | Wnt receptor compositions and methods | May 20, 2002 | Abandoned |
Array
(
[id] => 6846929
[patent_doc_number] => 20030166096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/152406
[patent_app_country] => US
[patent_app_date] => 2002-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63478
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10152406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/152406 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 19, 2002 | Abandoned |
Array
(
[id] => 6774165
[patent_doc_number] => 20030017503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Methods and labeled molecules for determining ligand binding to steroid receptors'
[patent_app_type] => new
[patent_app_number] => 10/151133
[patent_app_country] => US
[patent_app_date] => 2002-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6539
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151133 | Methods and labeled molecules for determining ligand binding to steroid receptors | May 19, 2002 | Abandoned |
Array
(
[id] => 6725065
[patent_doc_number] => 20030207377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/147507
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63508
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147507 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 16, 2002 | Abandoned |
Array
(
[id] => 6659394
[patent_doc_number] => 20030134378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/147504
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63479
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147504
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147504 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 16, 2002 | Abandoned |
Array
(
[id] => 6846920
[patent_doc_number] => 20030166087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/147486
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63478
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147486 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 16, 2002 | Abandoned |
Array
(
[id] => 6846924
[patent_doc_number] => 20030166091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/147498
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63478
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166091.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147498
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147498 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 16, 2002 | Abandoned |